Glucose-6-phosphate dehydrogenase deficiency medical therapy
|
Glucose-6-phosphate dehydrogenase deficiency Microchapters |
|
Differentiating Glucose-6-phosphate dehydrogenase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glucose-6-phosphate dehydrogenase deficiency medical therapy On the Web |
|
American Roentgen Ray Society Images of Glucose-6-phosphate dehydrogenase deficiency medical therapy |
|
FDA on Glucose-6-phosphate dehydrogenase deficiency medical therapy |
|
CDC on Glucose-6-phosphate dehydrogenase deficiency medical therapy |
|
Glucose-6-phosphate dehydrogenase deficiency medical therapy in the news |
|
Blogs on Glucose-6-phosphate dehydrogenase deficiency medical therapy |
|
Directions to Hospitals Treating Glucose-6-phosphate dehydrogenase deficiency |
|
Risk calculators and risk factors for Glucose-6-phosphate dehydrogenase deficiency medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]
Overview
The mainstay of treatment for G6PD deficiency is avoidance of the foods such as fava beans and drugs that cause hemolysis. Pharmacologic medical therapy is recommended among patients with chronic hemolysis. Blood transfusion can be considered in the acute phase of hemolysis.
Medical Therapy
- The mainstay of treatment for G6PD deficiency is avoidance of the foods such as fava beans and drugs that cause hemolysis.[1]
- Neonatal jaundice:
- Mild: no treatment
- Intermediate: phototherapy
- Severe: exchange transfusion
- Blood transfusion in acute phase of hemolysis
- Dialysis in acute kidney failure
- Folic acid for patients with chronic hemolysis[2]
Disease Name
- Adult
- Folic acid: 1 mg daily